Market Overview:
The global severe acute respiratory syndrome coronavirus (SARS) nucleic acid detection kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of SARS, rising demand for nucleic acid detection kits for diagnosis and treatment, and technological advancements in nucleic acid detection kits. However, the high cost of advanced nucleic acid detection kits may restrain the growth of the market. On the basis of type, the global severe acute respiratory syndrome coronavirus (SARS) nucleic acid detection kit market is segmented into dry PCR and fluorescence PCR. The fluorescence PCR segment is expected to grow at a higher CAGR than that of dry PCR during the forecast period owing to its advantages such as high sensitivity and specificity over other methods. Based on application, hospitals are expected to hold a larger share of the global severe acute respiratory syndrome coronavirus (SARS) nucleic acid detection kit market in 2018 followed by clinics due to increasing number of hospital admissions for SARS patients across regions.
 Nucleic Acid Detection Kit Industry Outlook.svg)
Product Definition:
A Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Nucleic Acid Detection Kit is a device used to detect the presence of the SARS virus in a sample. The kit is important for diagnosing and monitoring patients with suspected or confirmed cases of SARS.
Dry PCR:
Dry PCR, also known as molecular Beacons or Molecular Ligation and Detection (MLD), is a new technology that uses DNA probes to detect the SARS-CoV-2 virus. The technique has been used for other RNA and DNA viruses such as HIV-1, influenza A & B, Ebola & Marburg virus. It works by binding of the probe to the target sequence in the genome of an infected cell.
Fluorescence PCR:
Fluorescence Polymerase Chain Reaction (PCR) is a technique that involves the use of fluorescent dyes to amplify specific segments of DNA or RNA. The technology has been used in clinical laboratories for the detection and identification of genetic abnormalities in patients suffering from inherited diseases, infections, cancers, and other disorders. Fluorescence PCR is an extension to regular PCR which can be used for SARS-CoV-2 diagnosis as it provides higher sensitivity and specificity than conventional methods.
Application Insights:
Based on the application, the global severe acute respiratory syndrome coronavirus (SARS-CoV) nucleic acid detection kit market is segmented into hospital and clinic. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a large number of tests performed annually. SARS-CoV infection can be diagnosed by testing patient's swab or serum samples for presence of SARS-CoV RNA. Thus, rising incidence of severe acute respiratory syndrome coronavirus (SARS-CoV) infections is boosting demand for these kits at hospitals across the globe.
The Clinic segment is expected to grow at a lucrative rate during the forecast period due to increasing awareness about early diagnosis and effective treatment procedures for SARS-CoV infections that are currently available only at specialized clinics or hospitals equipped with these kits.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of advanced diagnostic techniques and rising incidence of SARS-CoV infections are some factors responsible for its large share. Moreover, government initiatives to raise awareness regarding coronavirus infection and encourage early diagnosis are expected to propel the demand for these tests in this region. For instance, as per CDC guidelines, all patients with suspected SARS-CoV infection should be tested by using an RT-PCR test or a culture method that is most appropriate for their condition (i.e., clinical specimen).
In Asia Pacific countries like China.
Growth Factors:
- Increasing demand for nucleic acid detection kits from research institutes and diagnostic laboratories for the detection of SARS virus.
- Growing awareness about SARS virus and its diagnosis among healthcare professionals is expected to boost the demand for nucleic acid detection kits in near future.
- Technological advancements in nucleic acid detection kits is anticipated to fuel the growth of this market over the forecast period.
- Rising number of outbreaks due to SARS virus across globe is expected to create opportunities for nucleic acid detection kit manufacturers in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Research Report
By Type
Dry PCR, Fluorescence PCR
By Application
Hospital, Clinic
By Companies
BioGerm, Geneodx, Liferiver, Mole, Sansure, Bioperfectus, Kinghawk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Report Segments:
The global Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit market is segmented on the basis of:
Types
Dry PCR, Fluorescence PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioGerm
- Geneodx
- Liferiver
- Mole
- Sansure
- Bioperfectus
- Kinghawk
 Nucleic Acid Detection Kit Market Overview.svg)
Highlights of The Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry PCR
- Fluorescence PCR
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Nucleic Acid Detection Kit Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Severe Acute Respiratory Syndrome Coronavirus (SARS) Nucleic Acid Detection Kit is a laboratory tool used to detect the presence of SARS-CoV nucleic acid in samples.
Some of the major players in the severe acute respiratory syndrome coronavirus(sars) nucleic acid detection kit market are BioGerm, Geneodx, Liferiver, Mole, Sansure, Bioperfectus, Kinghawk.
The severe acute respiratory syndrome coronavirus(sars) nucleic acid detection kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry PCR
5.2.2 Fluorescence PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry PCR
9.6.2 Fluorescence PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry PCR
10.6.2 Fluorescence PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry PCR
11.6.2 Fluorescence PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry PCR
12.6.2 Fluorescence PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry PCR
13.6.2 Fluorescence PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Severe Acute Respiratory Syndrome Coronavirus(SARS) Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioGerm
14.3.2 Geneodx
14.3.3 Liferiver
14.3.4 Mole
14.3.5 Sansure
14.3.6 Bioperfectus
14.3.7 Kinghawk
